Skip to main content
. 2020 Nov 30;12(12):3576. doi: 10.3390/cancers12123576

Figure 3.

Figure 3

Suggested treatment options for RRMM patients in advanced phases of the disease (>3 lines of therapy). Abbreviations: IsaPd: Isatuximab, pomalidomide, dexamethasone; EloPd: Elotuzumab, pomalidomide, dexamethasone; DPd: Daratumumab, pomalidomide, dexamethasone; PFS, progression-free survival.